Fundraising Fox

KinDex Pharmaceuticals

Seattle, US · Delaware corporation

Biotech

Founders & leadership

LB
Lincoln BouillonExecutive
NA
Neile A GraysonExecutive
JS
Jeffrey S BlandNamed on SEC filing

Board

JJ
Jeffrey J KatkeBoard director
RC
Roger ColmanBoard director
PS
Paul SchimmelBoard director

Reported raises · per SEC filings

Form D private placements

$7.5M disclosed across 3 rounds · 2014–2019

▶$900KraisedMay 2019 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey S BlandExecutive Officer
  • Brent EckDirector
  • Jeffrey J KatkeDirector
  • Paul SchimmelDirector
  • Dennis AusielloDirector
  • Michael HigginsExecutive Officer
Offering amount
$2M
Amount sold
$900K
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJun 2017 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Lincoln BouillonExecutive Officer
  • Jeffrey J KatkeDirector
  • Paul SchimmelDirector
  • Dennis AusielloDirector
  • Jeffrey S BlandExecutive Officer, Director
  • Michael HigginsDirector
  • Neile A GraysonExecutive Officer
  • Brent EckDirector
Offering amount
$1.3M
Amount sold
$1.1M
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedMar 2015 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey S BlandExecutive Officer, Director
  • Lincoln BouillonExecutive Officer
  • Jeffrey J KatkeDirector
  • Roger ColmanDirector
  • Neile A GraysonExecutive Officer
  • Paul SchimmelDirector
Offering amount
$10M
Amount sold
$5.5M
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Xconomy: KinDex Pharmaceuticals Receives $5,000,000 Series A Financing Roundxconomy.com · Mar 2014KinDex Pharmaceuticals launches with Series A Funding | PE Hubpehub.com · Mar 2014Startup Biotech, Kindex Pharmaceuticals, Launches With $5 Million In Pocket - BioSpacebiospace.com · Mar 2014

Frequently asked questions

How much funding has KinDex Pharmaceuticals raised?
KinDex Pharmaceuticals has disclosed $7.5M raised across 3 rounds.
Where is KinDex Pharmaceuticals headquartered?
KinDex Pharmaceuticals is headquartered in Seattle, US.